Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Patriot Scientific Corporation Releases Third Fiscal Quarter Report

What a mouthful.........

The Company's after-tax net loss of $5.6 million for the February 2011 quarter includes a provision for income taxes of $8.1 million as a result of recording a valuation allowance against the Company's deferred tax assets. This write-down of the deferred tax assets via a valuation allowance was based on authoritative financial accounting guidance, and represents a non-cash charge to the statement of operations.

I guess this is what forensic accounting gets you IMO.......

Share
New Message
Please login to post a reply